AQHA Archives

Racehorse doping prevention and identification focus of three research studies: Horsetalk 1/14/19

Press Release: Tackling the use of illicit substances in the horse world has advanced in recent month with three “tactical research” studies by the Racing Medication and Testing Consortium (RMTC). Tactical research studies focus on detecting, identifying and inhibiting the use of illicit substances. The first study to be published, L-and D-threo Ethylphenidate Concentrations, Pharmacokinetics and Pharmacodynamics in

Negative Hair Test Required for Entry in $250,000 Albuquerque Fall Championship: AQHA 08/24/17

Press Release: All horses entering the September 24, $250,000 Albuquerque Fall Quarter Horse Championship will be required to have a negative hair test. The negative test results will need to be submitted to the New Mexico Racing Commission by September 8. Nominations for the 440-yard stakes, which will for the first time in its three-year history offer

Animal Welfare Recommendations Approved: AQHA.COM 5/17/17

The AQHA Executive Committee approved several recommendations from the AQHA Animal Welfare Commission at the 2017 AQHA Convention. The recommendations ranged from adding specific medications to the AQHA forbidden drugs or substances list to creating educational efforts for specific animal-handling procedures to a recommendation to use all drug- and animal welfare-related fines to support the

ARCI Welfare, Integrity Conference Continues: The Horse 4/20/17

By: Edited Press Release The American Quarter Horse Association (AQHA) is pioneering cost-effective loaner integrity teams that provide investigative reinforcements for the sprint sport’s big-event days. That program was the main focus of Wednesday’s discussion on “Policing the Backside: A View from the Front Line” at the Association of Racing Commissioners International’s (ARCI) 83rd annual

Regulators Discuss Adding Backstretch Investigators: Blood-Horse 4/19/17

By: Frank Angst In an era where some states have faced budget cuts, racing regulators talked April 19 about creative ways to place more investigators on the backstretch as a way of discovering wrongdoing and deterring future bad behavior. The talk of such approaches was one of four panel discussions on a busy Wednesday at

Remington Park Institutes Hair Testing for Grade 1 Championship: AQHA.Com 4/18/17

By: Edited Press Release Remington Park will implement hair testing for its 440-yard, $250,000 Remington Park Championship (G1), which this year will be run on June 3. According to a press release issued by the track, horses invited to the Remington Park Championship will be required to be on grounds no later than May 15. Hair

New Form Of Familiar Anti-Inflammatory Granted FDA Approval: Paulick Report 8/6/16

By: Press Release For almost 10 years, Equioxx® (firocoxib) has been the only coxib non-steroidal anti-inflammatory drug (NSAID) approved for use in horses. Now, this once-daily treatment to control joint pain and inflammation associated with equine osteoarthritis, is approved by the FDA in tablet form, and will be available in the market early fall. Equioxx is

Animal Welfare: A Continuing Effort: AQHA 5/12/16

By: The American Quarter Horse Association The AQHA Executive Committee approved recommendations from the AQHA Animal Welfare Commission to continue to make strides for the benefit of American Quarter Horses. The health and well-being of the American Quarter Horse is the American Quarter Horse Association’s utmost concern. In accordance with AQHA’s mission statement, the

MMVS Temporarily Suspended: AQHA 3/7/16

By: AQHA Program temporarily halted pending further review. The misuse of medication in the racing American Quarter Horse industry continues to be a serious animal welfare issue, and one that AQHA, with the support of horsemen and the racing industry alike, is working to address. In 2013, AQHA announced the launch of its Multiple Medication

Follow Us

Quick Links

Learn About Our:

Who We Are:

SIGN UP TO RECEIVE RMTC COMMUNICATIONS

Follow Us

Quick Links

Learn About Our:

Who We Are: